Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New insights into the role of STAT3 in IBD.
Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ. Li Y, et al. Among authors: van der woude cj. Inflamm Bowel Dis. 2012 Jun;18(6):1177-83. doi: 10.1002/ibd.21884. Epub 2011 Oct 12. Inflamm Bowel Dis. 2012. PMID: 21994179 Review.
Roles of CD1d-restricted NKT cells in the intestine.
van Dieren JM, van der Woude CJ, Kuipers EJ, Escher JC, Samsom JN, Blumberg RS, Nieuwenhuis EE. van Dieren JM, et al. Among authors: van der woude cj. Inflamm Bowel Dis. 2007 Sep;13(9):1146-52. doi: 10.1002/ibd.20164. Inflamm Bowel Dis. 2007. PMID: 17476670 Review.
Local application of tacrolimus in distal colitis: feasible and safe.
van Dieren JM, van Bodegraven AA, Kuipers EJ, Bakker EN, Poen AC, van Dekken H, Nieuwenhuis EE, van der Woude CJ. van Dieren JM, et al. Among authors: van der woude cj, van dekken h, van bodegraven aa. Inflamm Bowel Dis. 2009 Feb;15(2):193-8. doi: 10.1002/ibd.20644. Inflamm Bowel Dis. 2009. PMID: 18825773 Clinical Trial.
Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
van Schaik FD, ten Kate FJ, Offerhaus GJ, Schipper ME, Vleggaar FP, van der Woude CJ, Stokkers PC, de Jong DJ, Hommes DW, van Bodegraven AA, Siersema PD, Oldenburg B; Dutch Initiative on Crohn and Colitis. van Schaik FD, et al. Among authors: van der woude cj, van bodegraven aa. Inflamm Bowel Dis. 2011 May;17(5):1108-16. doi: 10.1002/ibd.21467. Epub 2010 Sep 7. Inflamm Bowel Dis. 2011. PMID: 20824815
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's disease.
van der Woude CJ, Stokkers P, van Bodegraven AA, Van Assche G, Hebzda Z, Paradowski L, D'Haens G, Ghosh S, Feagan B, Rutgeerts P, Dijkstra G, de Jong DJ, Oldenburg B, Farhan M, Richard T, Dean Y, Hommes DW; Initiative on Crohn's and Colitis, The Netherlands. van der Woude CJ, et al. Among authors: van bodegraven aa, van assche g. Inflamm Bowel Dis. 2010 Oct;16(10):1708-16. doi: 10.1002/ibd.21252. Inflamm Bowel Dis. 2010. PMID: 20848453 Clinical Trial.
Role of defective autophagia and the intestinal flora in Crohn disease.
Regeling A, Somasundaram R, de Haar C, van der Woude CJ, Braat H, Peppelenbosch MP. Regeling A, et al. Among authors: van der woude cj. Self Nonself. 2010 Oct-Dec;1(4):323-327. doi: 10.4161/self.1.4.13990. Self Nonself. 2010. PMID: 21487507 Free PMC article. Review.
275 results